129-Pik3cbtm1.1Bvan/Cnbc
Status | Available to order |
EMMA ID | EM:11633 |
International strain name | 129-Pik3cbtm1.1Bvan/Cnbc |
Alternative name | p110beta PI3K-DEL21/22(129) |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Pik3cbtm1.1Bvan, |
Gene/Transgene symbol | Pik3cb |
Information from provider
Provider | Bart Vanhaesebroeck |
Provider affiliation | UCL Cancer Institute, University College London |
Additional owner | the University of Edinburgh |
Genetic information | Mice in which exons 21 and 22 from Pik3cb/p110beta are constitutively deleted by crossing to a cre-deleter strain - backcrossed onto 129 background. |
Phenotypic information | Homozygous:Homozygous Pik3cb/p110beta D21-22/D21-22 mice can be obtained but at reduced frequency, it depends on the genetic background.Heterozygous:Mice show reduced phenotypes of homozygous. |
Breeding history | Backcrossed onto 129Sv for more than 10 generations. |
References |
|
Homozygous fertile | females only |
Homozygous viable | not known |
Homozygous matings required | no |
Immunocompromised | not known |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Animals used for archiving | heterozygous 129S2/SvPasCrl |
Literature references
- The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.;Guillermet-Guibert Julie, Bjorklof Katja, Salpekar Ashreena, Gonella Cristiano, Ramadani Faruk, Bilancio Antonio, Meek Stephen, Smith Andrew J H, Okkenhaug Klaus, Vanhaesebroeck Bart, ;2008;Proceedings of the National Academy of Sciences of the United States of America;105;8292-7; 18544649
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).